Abstract
A common polymorphism of the gene encoding acyl-coenzyme A: cholesterol acyltransferase 1 (SOAT1), which is involved in the regulation of β-amyloid peptide generation, is associated with low brain amyloid load (P=0.03) and with low cerebrospinal fluid levels of cholesterol (P=0.005). This polymorphism of SOAT1 is also associated with reduced risk for Alzheimer's disease in ethnically distinct populations (P=0.0001, odds ratio: 0.6, 95% confidence interval 0.4–0.8).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Selkoe DJ . Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81: 741–766.
Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K . Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 1998; 95: 6460–6464.
Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P et al. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci USA 2001; 98: 5856–5861.
Rudel LL, Lee RG, Cockman TL . Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis. Curr Opin Lipidol 2001; 12: 121–127.
Puglielli L, Konopka G, Pack-Chung E, Ingano LA, Berezovska O, Hyman BT et al. Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat Cell Biol 2001; 3: 905–912.
Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I et al. A full genome scan for late onset alzheimer's disease. Hum Mol Genet 1999; 8: 237–245.
Myers A, Wavrant De-Vrieze F, Holmans P, Hamshere M, Crook R, Compton D et al. Full genome screen for Alzheimer disease: Stage II analysis. Am J Med Genet 2002; 114: 235–244.
Sullivan PF, Eaves LJ, Kendler KS, Neale MC . Genetic case-control association studies in neuropsychiatry. Arch Gen Psychiatry 2001; 58: 1015–1024.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944.
Thal DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K et al. Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 2000; 59: 733–748.
Thal DR, Rüb U, Orantes M, Braak H . Phases of Aß-deposition in the human brain and its relevance for the development of AD. Neurology 2002; 58: 1791–1800.
Braak H, Braak E Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239–259.
Dzeletovic S, Breuer O, Lund E, Diczfalusy U . Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem 1995; 225: 73–80.
Demeester N, Castro G, Desrumaux C, De Geitere C, Fruchart JC, Santens P et al. Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin: cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease. J Lipid Res 2000; 41: 963–974.
Montine TJ, Montine KS, Swift LL . Central nervous system lipoproteins in Alzheimer's disease. Am J Pathol 1997; 151: 1571–1575.
Mulder M, Ravid R, Swaab DF, de Kloet ER, Haasdijk ED, Julk J et al. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4. Alzheimer Dis Assoc Disord 1998; 12: 198–203.
Accad M, Smith SJ, Newland DL, Sanan DA, King Jr LE, Linton MF et al. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA: cholesterol acyltransferase 1. J Clin Invest 2000; 105: 711–719.
Hixson JE, Vernier DT . Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545–548.
Kokoris M, Dix K, Moynihan K, Mathis J, Erwin B, Grass P et al. High-throughput SNP genotyping with the Masscode system. Mol Diagn 2000; 5: 329–340.
Terwilliger JD, Ott J . Linkage disequilibrium between alleles at marker loci. In: Terwilliger JD and Ott J (eds). Handbook of Human Genetic Linkage. The Johns Hopkins University Press: Baltimore, 1994, p. 189–198.
Acknowledgements
We thank Ms. Esmeralda Garcia, Ms Christin Wilde, Mrs Andrea Walther, and Ms Estelle Obrist for their patient care and sampling. The technical expertise of Ms Anja Kerksiek is gratefully acknowledged. This work was supported in parts by grants of the Swiss Science National Foundation (32-65869.01) and the Roche Research Foundation (22-2001) to AP, by the Bundesministerium für Bildung, Forschung, Wissenschaft und Technologie (01EC9402) to DL and KvB, by the National Center for Competence in Research (NCCR) ‘Neuronal Plasticity and Repair’, and by the EU DIADEM program on Diagnosis of Dementia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wollmer, M., Streffer, J., Tsolaki, M. et al. Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease. Mol Psychiatry 8, 635–638 (2003). https://doi.org/10.1038/sj.mp.4001296
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001296
Keywords
This article is cited by
-
Abnormal brain cholesterol homeostasis in Alzheimer’s disease—a targeted metabolomic and transcriptomic study
npj Aging and Mechanisms of Disease (2021)
-
Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease
Cellular and Molecular Neurobiology (2021)
-
Relationship Between Genetic Variants of ACAT1 and APOE with the Susceptibility to Dementia (SADEM Study)
Molecular Neurobiology (2021)
-
Hypercholesterolemia negatively influences morphology and molecular markers of epithelial cells within the choroid plexus in rabbits
Fluids and Barriers of the CNS (2020)
-
Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer’s Disease (sAD)-Like Pathology
Molecular Neurobiology (2016)